Eneida Pardo

1.0k total citations
5 papers, 119 citations indexed

About

Eneida Pardo is a scholar working on Molecular Biology, Hematology and Biomedical Engineering. According to data from OpenAlex, Eneida Pardo has authored 5 papers receiving a total of 119 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Hematology and 1 paper in Biomedical Engineering. Recurrent topics in Eneida Pardo's work include Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Eneida Pardo is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Eneida Pardo collaborates with scholars based in United States. Eneida Pardo's co-authors include Archana Bommi‐Reddy, Péter Sandy, Robert J. Sims, Barbara M. Bryant, Jennifer A. Mertz, Shivangi Joshi, Richard C. Centore, Karen E. Gascoigne, Patricia J. Keller and Andrew R. Conery and has published in prestigious journals such as Cancer Research, eLife and SLAS DISCOVERY.

In The Last Decade

Eneida Pardo

4 papers receiving 117 citations

Peers

Eneida Pardo

MB

HEMAT

ONCOL

IMMUN

RNMI

Marisa Actis United States

Christopher Maisel United States

Ulf-Henrik Mellqvist Sweden

Venkata D. Yellapantula United States

Bharat Nandakumar United States

Julius Gräsel Australia

Ashraf Elghandour Egypt

Matthew R. Hart United States

Hikari Osaki United Kingdom

Titouan Cazaubiel France

Marisa Actis United States

Eneida Pardo

99 ×0.9

MB

40 ×0.9

HEMAT

44 ×2.2

ONCOL

6 ×0.6

IMMUN

2 ×0.3

RNMI

Citations per year, relative to Eneida Pardo Eneida Pardo (= 1×) peers Marisa Actis

Countries citing papers authored by Eneida Pardo

Since Specialization

Citations

This map shows the geographic impact of Eneida Pardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eneida Pardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eneida Pardo more than expected).

Fields of papers citing papers by Eneida Pardo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eneida Pardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eneida Pardo. The network helps show where Eneida Pardo may publish in the future.

Co-authorship network of co-authors of Eneida Pardo

This figure shows the co-authorship network connecting the top 25 collaborators of Eneida Pardo. A scholar is included among the top collaborators of Eneida Pardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eneida Pardo. Eneida Pardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Douthwaite, James L., Damian J. Houde, Eneida Pardo, et al.. (2025). Nanoscale direct-to-biology optimization of Cdk2 inhibitors. ChemRxiv.

2.

Caligiuri, Maureen, Erik Wilker, Lili Yao, et al.. (2023). FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer. Targeted Oncology. 18(2). 269–285. 20 indexed citations

3.

Franklin, G. Joseph, et al.. (2020). The Impact of Variable Selection Coverage on Detection of Ligands from a DNA-Encoded Library Screen. SLAS DISCOVERY. 25(5). 515–522. 12 indexed citations

4.

Conery, Andrew R., Richard C. Centore, Adrianne Neiss, et al.. (2016). Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. eLife. 5. 84 indexed citations

5.

Normant, Emmanuel, Richard Cummings, Steven F. Bellon, et al.. (2012). Abstract LB-237: In vitro and in vivo characterization of CPI-267203, a potent Inhibitor of bromodomain-containing proteins. Cancer Research. 72(8_Supplement). LB–237. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact